Home
Resources
Meet the Experts
Login
Register for free
Resources
Guidelines
Publications - long term use
Guidelines
Guideline on core summary for product characteristics for human albumin solution (Revision 3)
European Medicines Agency (EMA) | 2018
Human Albumin Solution Infusion (HAS) – Guideline for practice
North West Anglia, NHS Foundation Trust | 2020
Guidelines for the Usage of Human Albumin Solution (HAS)
NHS National Services Scotland, National Plasma Product Expert Advisory Group | 2018
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
American Association for the Study of Liver Diseases (AASLD) | 2021
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines
Italian Association for the Study of the Liver (AISF) | 2021
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
European Association for the Study of the Liver |2018
Chinese guidelines on the management of liver cirrhosis
XY Xu et. al | 2020
Guidelines on the management of ascites in cirrhosis
British Society of Gastroenterology in collaboration with British Association for the Study of the Liver | 2021
Publications of long term albumin use
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P. Caraceni et. al | 2018
Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference
M. Tufoni et al. | 2019
A nurse-led albumin infusion service dramatically reduces the need for therapeutic paracentesis in the outpatient day procedure setting
K. Rutland et. al | 2020
Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS)
J. Trotter et. al | 2005
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial
E. Solà et. al | 2018
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli | 2019